End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
322.60 SEK | -3.12% | +2.19% | +3.90% |
01-14 | Nordnet savers have continued to bottom fish in early 2025 | FW |
01-13 | Lannebo Mixfond Offensiv decreased 0.6 percent in December - heavy loss for Novo Nordisk | FW |
Evolution of the Average Target: Boliden
Evolution of the Target Price: Boliden
Changes in Analyst Recommendations: Boliden
Analyst Opinion | 4m Revision of opinion | Divergence of analysts' opinions | Divergence of Target Price | Ecart obj. / dr | ||
---|---|---|---|---|---|---|
+5.18% | ||||||
+6.61% | ||||||
+30.65% | ||||||
+41.39% | ||||||
-23.61% | ||||||
+27.64% | ||||||
+16.37% | ||||||
+23.49% | ||||||
+33.47% | ||||||
Average | +17.91% | |||||
Weighted average by Cap. | +17.84% |
Analysts' Consensus
Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
alphavalue | Varun Sikka |
BNP Paribas | |
Barclays |
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BOL Stock
- Consensus Boliden
MarketScreener is also available in this country: United States.
Switch edition